SEC Form 4 · accession 0001061983-17-000064
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fady Ibraham Malik
Officer — EVP Research & Development
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 8:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2017 | M | 694 | $11.10 | A | 47,540 | D | |
| Common Stock | Nov 1, 2017 | S | 178 | $13.05 | D | 47,362 | D | |
| Common Stock | Nov 1, 2017 | M | 2,639 | $11.10 | A | 50,001 | D | |
| Common Stock | Nov 1, 2017 | S | 800 | $13.10 | D | 49,201 | D | |
| Common Stock | Nov 1, 2017 | M | 694 | $11.10 | A | 49,895 | D | |
| Common Stock | Nov 1, 2017 | S | 300 | $13.125 | D | 49,595 | D | |
| Common Stock | Nov 1, 2017 | M | 2,639 | $11.10 | A | 52,234 | D | |
| Common Stock | Nov 1, 2017 | S | 1,300 | $13.15 | D | 50,934 | D | |
| Common Stock | Nov 1, 2017 | S | 100 | $13.175 | D | 50,834 | D | |
| Common Stock | Nov 1, 2017 | S | 300 | $13.20 | D | 50,534 | D | |
| Common Stock | Nov 1, 2017 | S | 400 | $13.225 | D | 50,134 | D | |
| Common Stock | Nov 1, 2017 | S | 200 | $13.25 | D | 49,934 | D | |
| Common Stock | Nov 1, 2017 | S | 200 | $13.30 | D | 49,734 | D | |
| Common Stock | Nov 1, 2017 | S | 400 | $13.35 | D | 49,334 | D | |
| Common Stock | Nov 1, 2017 | S | 300 | $13.55 | D | 49,034 | D | |
| Common Stock | Nov 1, 2017 | S | 600 | $13.60 | D | 48,434 | D | |
| Common Stock | Nov 1, 2017 | S | 900 | $13.65 | D | 47,534 | D | |
| Common Stock | Nov 1, 2017 | S | 400 | $13.675 | D | 47,134 | D | |
| Common Stock | Nov 1, 2017 | S | 100 | $13.80 | D | 47,034 | D | |
| Common Stock | Nov 1, 2017 | S | 843 | $13.80 | D | 46,191 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $11.10 | Nov 1, 2017 | M | 2,639 | D | Mar 26, 2009 | Feb 26, 2019 | Common Stock | 2,639 | 2,639 | D |
| Incentive Stock Option (right to buy) | $11.10 | Nov 1, 2017 | M | 2,639 | D | Mar 26, 2009 | Feb 26, 2019 | Common Stock | 2,639 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $11.10 | Nov 1, 2017 | M | 694 | D | Mar 26, 2009 | Feb 26, 2019 | Common Stock | 694 | 694 | D |
| Non-Qualified Stock Option (right to buy) | $11.10 | Nov 1, 2017 | M | 694 | D | Mar 26, 2009 | Feb 26, 2019 | Common Stock | 694 | 0 | D |
Explanation of responses
- F1The exercise(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29,2017.
- F2The sale(s) reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2017.